GlassScriptPhysician profile
Parteek One Singla
NPI 1184003006
$2,196.06
in general payments reported to CMS, 2019-2025
22 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.70 · 2021: $189 · 2022: $658 · 2023: $356 · 2024: $460 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,298 · Education: $17.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.17 |
| Education | $17.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $423.24 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $374.27 | 2020-2025 | Odomzo, Blu-U, Ilumya |
| Integra Lifesciences Corporation | $297.81 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Abbvie INC. | $229.89 | 2022-2025 | Skyrizi, Rinvoq |
| Biohaven Pharmaceuticals, INC. | $124.10 | 2021 | |
| Organogenesis INC. | $104.82 | 2025 | Via Matrix, Nushield, Novachor |
| Musculoskeletal Transplant Foundation INC. | $95.85 | 2025 | |
| Access Pro Medical, LLC | $90.25 | 2023 | Matriderm |
| Janssen Biotech, INC. | $74.35 | 2020-2025 | Tremfya |
| Convatec INC. | $72.71 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $51.14 | 2024-2025 | Dupixent, Libtayo |
| Tempus Ai, INC | $47.88 | 2024 | |
| Arcutis Biotherapeutics, INC. | $29.21 | 2023-2024 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $27.65 | 2022 | |
| Allergan, INC. | $27.43 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $25.48 | 2024 | Otezla |
| Genzyme Corporation | $24.21 | 2022 | |
| Galderma Laboratories, L.P. | $17.46 | 2023 | |
| Almirall LLC | $15.90 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.31 | 2025 | |
| Dermavant Sciences, INC. | $14.26 | 2023 | Vtama |
| Strata Skin Sciences, INC. | $12.84 | 2023 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parteek Singla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.